4processed
Form 4 — Insider Transaction
Avalo Therapeutics, Inc.(AVTX)
Filing Date
June 23, 2026
Accepted
June 23, 2026
Accession No.
0001918845-26-000020
CIK
0001534120
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Doyle Mittie | Chief Medical Officer | Other | 1.4K | $8.04 | — | 53.2K | Common Stock | Jun 23, 2026 |
| Doyle Mittie | Chief Medical Officer | Other | 1.4K | $18 | — | 51.8K | Common Stock | Jun 23, 2026 |
| Doyle Mittie | Chief Medical Officer | Other | 1.4K | $0 | — | 116.9K | Stock Option (Right to Buy) | Jun 23, 2026 |